SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | -106.63 |
| Book Value / Share | -24.11 |
| Price / Book | n/a |
| NCAV ($M) | -115.08 |
| NCAV / Share | -26.02 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.01 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.05 |
| Current Ratio | 0.05 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.05 |
| Assets | 14.51 |
| Liabilities | 121.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Highbridge Capital Management Llc | 9.99 | ||
| 13G | Context Capital Management, LLC |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| BIEI – Premier Biomedical, Inc. | BIMT – Bitmis Corp. |
| BIOE – Bio Essence Corporation | BIXT – Bioxytran, Inc. |
| BLFE – BioLife Sciences Inc. |
Financial data and stock pages provided by
Fintel.io